Takeda Pharmaceutical Ltd ADR(TAK-N)NYSE
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr03/2025 | Fiscal Yr03/2026 | |
|---|---|---|---|---|
| Average Estimate | N/A | N/A | 1.58 | 1.57 |
| Number of Estimates | 0 | 0 | 2 | 3 |
| High Estimate | N/A | N/A | 1.63 | 1.77 |
| Low Estimate | N/A | N/A | 1.53 | 1.36 |
| Prior Year | 0.51 | 0.00 | 1.67 | 1.58 |
| Growth Rate Est. (year over year) | +195,782.35% | N/A | -5.39% | -0.63% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $0.44 | $0.56 | $0.00 | $0.51 |
| Estimate | $0.39 | $0.37 | N/A | N/A |
| Difference | +0.05 | +0.19 | N/A | N/A |
| Surprise | +12.82% | +51.35% | N/A | N/A |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.50
3 Mths Ago4
4.50
2 Mths Ago4
4.50
1 Mth Ago4
4.50
Current4
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 4 | 4 | 4 | 4 |
3 | 3 | 3 | 3 | |
| Holds | 1 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell